Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/15/2006 | US7091220 Substituted indole Mannich bases |
08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
08/15/2006 | US7091204 Sulfonamides |
08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
08/15/2006 | US7091187 Using steroid; autoimmune disease |
08/15/2006 | US7091022 Mitogen activated kinase |
08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
08/15/2006 | CA2256309C Amidino protease inhibitors |
08/15/2006 | CA2238376C Benzofuran carboxamides and sulphonamides |
08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
08/15/2006 | CA2168193C Aryalkyl-thiadiazinones |
08/10/2006 | WO2006084017A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
08/10/2006 | WO2006083908A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
08/10/2006 | WO2006082952A1 Amide compound |
08/10/2006 | WO2006082492A1 Azabicyclo derivatives as anti-inflammatory agents |
08/10/2006 | WO2006082071A1 Method for producing a drug extract that contains hydroxystilbene |
08/10/2006 | WO2006082068A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
08/10/2006 | WO2006081609A1 Molecules and chimeric molecules thereof |
08/10/2006 | WO2004060381A8 Rabbit skin comprising biological active substance and its use |
08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
08/10/2006 | US20060178516 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
08/10/2006 | US20060178420 Indole derivatives as anti-inflammatory agents |
08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
08/10/2006 | US20060178368 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
08/10/2006 | US20060177898 Methods for producing modified glycoproteins |
08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
08/10/2006 | US20060177517 Antiinflammtory agent and antiinflammatory medical material |
08/10/2006 | US20060177443 Integrin antagonists |
08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
08/10/2006 | US20060177419 Stimulating neutrophil function to treat inflammatory bowel disease |
08/10/2006 | US20060177382 Delivery of antiemetics through an inhalation route |
08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
08/10/2006 | CA2596754A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders |
08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
08/10/2006 | CA2596171A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
08/10/2006 | CA2595860A1 Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
08/09/2006 | EP1688439A1 Fused protein composition |
08/09/2006 | EP1688436A1 Composition of antibody capable of specifically binding ccr4 |
08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
08/09/2006 | EP1688413A1 Benzoxazole derivatives for the prophylaxis and treatment of inflammatory bowel diseases |
08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
08/09/2006 | EP1688149A1 Paste formulations comprising silica |
08/09/2006 | EP1688144A1 Ophthalmic compositions containing quinolone-antibiotics |
08/09/2006 | EP1687320A1 Novel analgesic compounds, extracts containing same and methods of preparation |
08/09/2006 | EP1687311A1 Novel compounds |
08/09/2006 | EP1687259A1 Cyclopentyl derivates |
08/09/2006 | EP1686970A2 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease |
08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
08/09/2006 | EP1395238B1 Skin preparation |
08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
08/09/2006 | EP1300411B1 Novel disaccharides with anti-arthritic action |
08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
08/09/2006 | EP1076553B1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
08/09/2006 | CN1816625A Dna-based aptamers for human cathepsin g |
08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
08/09/2006 | CN1816549A Inhibitors of phosphatidylinositol 3-kinase |
08/09/2006 | CN1816523A N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
08/09/2006 | CN1814260A Chinese medicine for treating blood stagnation disease |
08/09/2006 | CN1814242A Medicinal liquor for treating wind-cold, numbness and swelling pain disease |
08/09/2006 | CN1814233A Wind-repellent collateral-flow-activating pain-relieving medicine of Ramulus Coranthi |
08/09/2006 | CN1814232A Wind-repellent collateral-flow-activating pain-relieving medicine of Herba Cissampeloris Pareirae |
08/09/2006 | CN1814231A Collateral-flow-activating pain-relieving medicine of Rhizoma stanhlianthi Thonelii |
08/09/2006 | CN1814230A Collateral-flow-activating pain-relieving medicine of Herba Vicicae Amoenae |
08/09/2006 | CN1814229A Damp-repellent pain-relieving medicinal liquor of Radix Vaccinii Fragilis |
08/09/2006 | CN1814228A Radix-Gynurae-Bodinieri collateral-flow-activating pain-relieving ointment for treating affection by dampness |
08/09/2006 | CN1814217A Chinese medicine composition for treating rheumatoid arthritis and use thereof |
08/09/2006 | CN1814213A Wind-repellent pain-relieving medicine of |
08/09/2006 | CN1814210A Collateral-flow-activating pain-relieving medicine of Radix Ardisiae Punctate |
08/09/2006 | CN1814204A Damp-repellent pain-relieving ointment of Radix seu Herba Heteropogonis Contorti |
08/09/2006 | CN1814203A Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls |
08/09/2006 | CN1814202A Damp-repellent pain-relieving medicinal liquor of Rhizoma et Radix caulophy lei |
08/09/2006 | CN1814192A Medicine for treating infant's fever and cough and preparing method |
08/09/2006 | CN1814188A Vitaminc lonicera and forsythia capsule and preparing method |
08/09/2006 | CN1814181A Wind-repellent collateral-flow-activating pain-relieving medicine of Semen Daturae |
08/09/2006 | CN1814180A Collateral-flow-activating pain-relieving medicine of Herba Paederiae |
08/09/2006 | CN1814179A Collateral-flow-activating pain-relieving medicine of Ramulus et Folium Vaccinii |
08/09/2006 | CN1814178A Damp-repellent pain-relieving medicinal liquor of Radix seu Folium Dolichi |
08/09/2006 | CN1814160A Wind-repellent collateral-flow-activating pain-relieving method of Herba Androsacis Umbellatae |
08/09/2006 | CN1814157A Chinese medicine preparation for detoxicating and pain-relieving, preparation method and quality control method |